DG Comp clears Merck/Schering Plough
Friday, 23 October 2009
Rosalind Donald
The European Commission has today approved US pharmaceuticals company Merck’s proposed $31 billion acquisition of US-based health-care company Schering-Plough.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top